Dr. Nilofer S. Azad is Professor of Oncology at Johns Hopkins University School of Medicine and serves as the Associate Cancer Center Director for Clinical Research for the Johns Hopkins Sidney Kimmel Cancer Center. Dr. Azad earned her medical degree and completed a residency in internal medicine at Baylor College of Medicine in Houston, Texas. She then completed a fellowship in oncology and hematology at the National Institute of Health's National Cancer Institute in Bethesda, Maryland where she served as chief fellow. Dr. Azad’s research focused on early phase drug development and the intersection of moving exciting laboratory findings into patients for new treatment options Dr. Azad joined the faculty at the Kimmel Cancer Center in 2008. Dr. Azad’s clinical expertise is in cancers of the gastrointestinal tract, with a concentration in colorectal cancer, cholangiocarcinoma and pancreaticobiliary tract cancer. Her research efforts are dedicated to developing new drug combinations for patients with advanced cancer. In particular, Dr. Azad’s laboratory and clinical trials explore epigenetic therapy in combination with chemotherapy and immunotherapy to improve survival for patients, as well as molecularly targeted drugs. She is an active clinical trialist, leading multiple clinical trials of molecularly targeted agents for advanced cancer patients. Dr. Azad has received numerous grants for her work from entities such as the NCI (National Cancer Center), American Cancer Society, American Society of Clinical Research, Breakthrough Cancer Foundation, the Lustgarten Foundation, The Gateway Foundation, and the National Comprehensive Cancer Network, among others. She served as Principal for Johns Hopkins on the AACR Stand Up 2 Cancer Colorectal Cancer Dream Team and is a member of the Stand Up 2 Cancer Epigenetics Dream Team, leading the GI cancer initiatives for the group. Dr. Azad is a national leader in GI cancer, including serving as a member of the national NCI Colon Cancer Task Force and as Co-Chair of the Scientific and Medical Advisory Board for the Cholangiocarcinoma Foundation. She has a presidential appointment to the National Cancer Advisory Board. Dr. Azad is rated as a Distinguished provider by MediFind in the treatment of Lynch Syndrome. Her top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Colorectal Cancer, Pancreatic Cancer, Hepato-Pancreato-Biliary Surgery, and Colonoscopy.

Joshua Levin is a General Surgeon and a Colorectal Surgeon in Bel Air, Maryland. Dr. Levin is rated as an Experienced provider by MediFind in the treatment of Lynch Syndrome. His top areas of expertise are Familial Colorectal Cancer, Lynch Syndrome, Colorectal Cancer, Rectal Prolapse, and Hernia Surgery. Dr. Levin is currently accepting new patients.

Dr. Vivek A. Patil is a colorectal surgeon affiliated with Sibley Memorial Hospital and Suburban Hospital, where he serves as chairman of colorectal surgery, as well as Shady Grove Adventist Hospital and Holy Cross Hospital. He practices out of Colorectal Surgery of Maryland and Washington, D.C., located in Bethesda, Maryland. Dr. Patil has an expertise minimally-invasive surgery, including laparoscopy and robotic surgery, to treat benign and malignant conditions of the colon and rectum. He has special interests in anorectal conditions, inflammatory bowel disease and pelvic floor disorders. Dr. Patil earned his medical degree from Georgetown University School of Medicine. He completed a residency in general surgery at Lenox Hill Hospital, where he participated in surgical research and received the John O. Vieta, M.D. Award for Surgical Excellence and Compassionate Care. Dr. Patil also completed a fellowship in colorectal surgery at Washington Hospital Center. Dr. Patil is a fellow of the American College of Surgeons and the American Society of Colon and Rectal Surgeons. Dr. Patil has been consistently named one of Washingtonian Magazine’s Top Doctors. Dr. Patil is rated as a Distinguished provider by MediFind in the treatment of Lynch Syndrome. His top areas of expertise are Hemorrhoids, Rectal Prolapse, Colorectal Cancer, Hemorrhoidectomy, and Ileostomy.

Syed Nasir is a Hematologist and an Oncologist in Towson, Maryland. Dr. Nasir is rated as a Distinguished provider by MediFind in the treatment of Lynch Syndrome. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Lynch Syndrome, and Paget Disease of the Breast.

Ilene S. Browner, M.D. specializes in geriatric oncology. Dr. Browner is rated as a Distinguished provider by MediFind in the treatment of Lynch Syndrome. Her top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, and Endoscopy.

Dung Le, M.D. is a professor of oncology at the Johns Hopkins University School of Medicine and member of the Johns Hopkins Kimmel Cancer Center. Her research interests include novel approaches to patients with gastrointestinal malignancies. She has served as the principal investigator (PI) on many clinical trials focused on testing immunotherapy in patients with gastrointestinal malignancies and she has also served as the national PI on several studies including: anti-programmed death-1 (PD-1) in tumors with mismatch repair deficiency; a clinical trial in advanced pancreatic cancer patients evaluating the safety, tolerability and immune response to CRS-207, a listeria vaccine platform which has been modified to express the tumor antigen mesothelin; a multi-center, phase 2 study testing CRS-207 as a boost to allogenic pancreatic tumor cells transfected with GM-CSF gene (GVAX) for treatment of advanced pancreatic adenocarcinoma (PDA); a trial testing GVAX/ipilimumab in the maintenance setting for metastatic pancreatic cancer; and GVAX/CRS-207 +/- nivolumab in metastatic pancreatic cancer. These studies incorporate extensive laboratory correlates and have involved collaborations with clinicians and bench scientists with expertise in the fields of immunotherapy and cancer genomics. Dr. Le is rated as an Advanced provider by MediFind in the treatment of Lynch Syndrome. Her top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Gastroesophageal Junction Cancer, and Familial Pancreatic Cancer.

Dr. Daniel Laheru is a cancer specialist in Baltimore, caring for patients with pancreatic cancer, colorectal cancer and neuroendocrine cancers. Dr. Laheru serves as co-director of the Skip Viragh Center for Pancreas Cancer Clinical Research and Patient Care at Johns Hopkins Medicine. Dr. Laheru received his undergraduate degree in chemistry from The University of Utah. He earned his M.D. at Baylor College of Medicine. He completed his residency at The University of Utah Hospital and Clinics and performed a fellowship in medical oncology at The Johns Hopkins University School of Medicine and The Johns Hopkins Oncology Center. Dr. Laheru joined the Johns Hopkins faculty in 2001. Dr. Laheru's research interests include pancreatic cancer and chemotherapy resistance in pancreatic cancer. With Elizabeth Jaffee, M.D., he developed a vaccine that supercharges the immune system and causes immune cells, which tend to be tolerant of cancer, to seek out and kill pancreatic cancer cells throughout the body. He has given numerous invited talks on pancreatic cancer and other cancers both nationally and internationally. He has authored over 200 papers focused on pancreatic cancer. Dr. Laheru serves as associate editor of Annals of Pancreatic Cancer. He has been recognized by the American Society of Clinical Oncology with the Young Investigator Award, by the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins as an Isaac and Catharine Hecht Scholar and has been elected to the Miller-Coulson Academy of Clinical Excellence. He is a member of the American College of Physicians, the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Laheru is rated as an Advanced provider by MediFind in the treatment of Lynch Syndrome. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy.

Fellowship trained in both colon and rectal surgery, Dr. Somerville has been in practice since 2005. He specializes in colorectal cancer, diverticular disease and IBD, and is an advanced laparoscopic/minimally invasive surgeon with extensive experience treating a broad range of anorectal diseases, as well. www.somsurgery.com. Dr. Somerville is rated as an Advanced provider by MediFind in the treatment of Lynch Syndrome. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Lynch Syndrome, Bladder Reconstruction, and Small Bowel Resection.

As an active participant in the medical community, Mohit Narang, M.D. has served as a primary investigator and research assistant on many trials. During Dr. Narang’s fellowship, he was honored with the invitation to attend the Masterclass in Clinical Oncology at Montecatini, Italy by the European School of Oncology. He holds professional memberships with the American Society of Clinical Oncology, American Society of Hematology, as well as the European Society of Medical Oncology. Learn more at marylandoncology.com. Dr. Narang is rated as an Advanced provider by MediFind in the treatment of Lynch Syndrome. His top areas of expertise are Multiple Myeloma, Agranulocytosis, Paget Disease of the Breast, Thrombocytopenia, and Bone Marrow Transplant.

William Houck is an Oncologist in Baltimore, Maryland. Dr. Houck is rated as an Advanced provider by MediFind in the treatment of Lynch Syndrome. His top areas of expertise are Paget Disease of the Breast, Lung Cancer, Chronic Lymphocytic Leukemia (CLL), and Chronic B-Cell Leukemia (CBCL).

Learn more at marylandoncology.com. Dr. Sastry is rated as an Advanced provider by MediFind in the treatment of Lynch Syndrome. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Iron Deficiency Anemia, and Childhood Iron Deficiency Anemia.

"A colorectal surgeon, Dr. Bafford specializes in the treatment of colorectal cancer, inflammatory bowel disease, and benign diseases of the colon, rectum and anus. ""These diseases are very treatable. The surgeries I perform are effective at curing cancer or treating colitis, which allows my patients back to the quality of life they want to have. It's very rewarding to see that type of recovery with so many of my patients,"" she says. Dr. Bafford's special interests include laparoscopic and robotic minimally invasive surgery, approaches that are associated with less pain and a faster recovery. Treatments she offers include surgical treatment of inflammatory bowel disease, sphincter-sparing surgery and organ preservation for rectal cancer, surgery for anorectal disorders, minimally invasive surgery for diverticulitis, treatment of rectal prolapse, and screening and therapeutic colonoscopy. Dr. Bafford has authored or co-authored numerous publications in leading peer-reviewed scientific journals and textbooks. Her research interests are in the pathophysiology of colorectal cancer, disparities in colorectal surgery and the surgical management of inflammatory bowel disease. Her passion and dedication have earned her a consistent spot on Baltimore magazine's ""Top Doctor"" lists for colon and rectal surgery. Videos Andrea Chao Bafford M.D.Colorectal Surgeon Research Summary Dr. Bafford's research has largely focused on IBD. Utilizing institutional databases and the NSQIP IBD, she has investigated perioperative outcomes in IBD patients as they relate to sex, immunosuppressive medical therapy, trauma, preoperative drainage of abscesses, and fecal diversion. She has also published on the microbiota of perianal Crohn’s disease with the help of an intramural grant. In addition, through interdepartmental collaboration, Dr. Bafford has contributed towards intestinal organoid preparation and 3D colon cancer organoid development used to study immune responses to intestinal infections, intestinal immunity, and colon cancer pathogenesis.". Dr. Bafford is rated as an Advanced provider by MediFind in the treatment of Lynch Syndrome. Her top areas of expertise are Crohn's Disease, Ulcerative Colitis, Familial Colorectal Cancer, Hernia Surgery, and Ileostomy.

Edward Lee, M.D. was named one of Baltimore’s “Top Doc’s” by Baltimore Magazine in 2000 and 2002. After receiving additional training in Hematology and Medical Oncology at the University of Maryland in 1984, he remained on faculty until 1997. During his academic career, Dr. Lee was chairman of the training program for five years, started the Bone Marrow Transplant Program at the University of Maryland in 1993, and wrote 50 original articles on leukemia, lymphoma and related diseases. In 1997, Dr. Lee entered private practice as Chief of Hematology and Medical Oncology at Sinai Hospital. Practicing in Columbia since 2001, Dr. Lee treats patients with all forms of cancer, maintaining a particular interest in breast cancer, leukemia, and lymphomas. Learn more at marylandoncology.com. Dr. Lee is rated as an Advanced provider by MediFind in the treatment of Lynch Syndrome. His top areas of expertise are Polycythemia Vera, Paget Disease of the Breast, Breast Cancer, and Primary Lymphoma of the Brain.

Irina Bernescu is a Colorectal Surgeon in Columbia, Maryland. Dr. Bernescu is rated as an Advanced provider by MediFind in the treatment of Lynch Syndrome. Her top areas of expertise are Anal Cancer, Familial Colorectal Cancer, Hemorrhoids, Hernia Surgery, and Colonoscopy.

James Zalucki is a Colorectal Surgeon in Ellicott City, Maryland. Dr. Zalucki is rated as an Advanced provider by MediFind in the treatment of Lynch Syndrome. His top areas of expertise are Hemorrhoids, Mesenteric Venous Thrombosis, Proctitis, Ureteroscopy, and Hernia Surgery.

Md Siddiqui is a Hematologist Oncology specialist and a Hematologist in Salisbury, Maryland. Dr. Siddiqui is rated as an Experienced provider by MediFind in the treatment of Lynch Syndrome. His top areas of expertise are Pulmonary Embolism, Inflammatory Breast Cancer, Angiosarcoma, and Childhood Iron Deficiency Anemia. Dr. Siddiqui is currently accepting new patients.

Panayotis Ledakis is a Hematologist in Baltimore, Maryland. Dr. Ledakis is rated as a Distinguished provider by MediFind in the treatment of Lynch Syndrome. His top areas of expertise are Appendix Cancer, Desmoplastic Small Round Cell Tumor, Anemia, Colorectal Cancer, and Ureteroscopy.

Myo Min is a Hematologist and an Oncologist in Bel Air, Maryland. Dr. Min is rated as a Distinguished provider by MediFind in the treatment of Lynch Syndrome. His top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Colorectal Cancer, and Large-Cell Immunoblastic Lymphoma. Dr. Min is currently accepting new patients.

Sandy Kotiah is a Hematologist in Baltimore, Maryland. Dr. Kotiah is rated as a Distinguished provider by MediFind in the treatment of Lynch Syndrome. Her top areas of expertise are Neuroendocrine Tumor, Paget Disease of the Breast, Anemia, Lynch Syndrome, and Bone Marrow Aspiration.

Rabindra Paul is a Hematologist and an Oncologist in Snow Hill, Maryland. Dr. Paul is rated as a Distinguished provider by MediFind in the treatment of Lynch Syndrome. His top areas of expertise are Inflammatory Breast Cancer, Colorectal Cancer, Paget Disease of the Breast, Familial Colorectal Cancer, and Bone Marrow Aspiration.